André J - Search Results

1

PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Delyon J, Servy A, Laugier F, André J, Ortonne N, Battistella M, Mourah S, Bensussan A, Lebbé C, Dumaz N. Delyon J, et al. Among authors: andre j. Oncogene. 2017 Jun 8;36(23):3252-3262. doi: 10.1038/onc.2016.469. Epub 2017 Jan 16. Oncogene. 2017. PMID: 28092671

2

Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.

Laugier F, Delyon J, André J, Bensussan A, Dumaz N. Laugier F, et al. Among authors: andre j. Oncogene. 2016 Sep 22;35(38):5070-7. doi: 10.1038/onc.2016.39. Epub 2016 Mar 14. Oncogene. 2016. PMID: 26973244

3

ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.

Marquette A, André J, Bagot M, Bensussan A, Dumaz N. Marquette A, et al. Among authors: andre j. Nat Struct Mol Biol. 2011 May;18(5):584-91. doi: 10.1038/nsmb.2022. Epub 2011 Apr 10. Nat Struct Mol Biol. 2011. PMID: 21478863

4

Driver KIT mutations in melanoma cluster in four hotspots.

Dumaz N, André J, Sadoux A, Laugier F, Podgorniak MP, Mourah S, Lebbé C. Dumaz N, et al. Among authors: andre j. Melanoma Res. 2015 Feb;25(1):88-90. doi: 10.1097/CMR.0000000000000116. Melanoma Res. 2015. PMID: 25304235

5

RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma.

Laugier F, Finet-Benyair A, André J, Rachakonda PS, Kumar R, Bensussan A, Dumaz N. Laugier F, et al. Among authors: andre j. Oncotarget. 2015 Sep 29;6(29):28120-31. doi: 10.18632/oncotarget.4866. Oncotarget. 2015. PMID: 26356562 Free PMC article.

6

PARKIN Inactivation Links Parkinson's Disease to Melanoma.

Hu HH, Kannengiesser C, Lesage S, André J, Mourah S, Michel L, Descamps V, Basset-Seguin N, Bagot M, Bensussan A, Lebbé C, Deschamps L, Saiag P, Leccia MT, Bressac-de-Paillerets B, Tsalamlal A, Kumar R, Klebe S, Grandchamp B, Andrieu-Abadie N, Thomas L, Brice A, Dumaz N, Soufir N. Hu HH, et al. Among authors: andre j. J Natl Cancer Inst. 2015 Dec 17;108(3). doi: 10.1093/jnci/djv340. Print 2016 Mar. J Natl Cancer Inst. 2015. PMID: 26683220

7

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.

Vallarelli AF, Rachakonda PS, André J, Heidenreich B, Riffaud L, Bensussan A, Kumar R, Dumaz N. Vallarelli AF, et al. Among authors: andre j. Oncotarget. 2016 Aug 16;7(33):53127-53136. doi: 10.18632/oncotarget.10634. Oncotarget. 2016. PMID: 27449293 Free PMC article.

8

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma.

Tétu P, Delyon J, André J, Reger de Moura C, Sabbah M, Ghanem GE, Battistella M, Mourah S, Lebbé C, Dumaz N. Tétu P, et al. Among authors: andre j. Cancers (Basel). 2020 Apr 25;12(5):1062. doi: 10.3390/cancers12051062. Cancers (Basel). 2020. PMID: 32344828 Free PMC article.

9

Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations.

Chraybi M, Abd Alsamad I, Copie-Bergman C, Baia M, André J, Dumaz N, Ortonne N. Chraybi M, et al. Among authors: andre j. Hum Pathol. 2013 Sep;44(9):1902-11. doi: 10.1016/j.humpath.2013.01.025. Epub 2013 May 9. Hum Pathol. 2013. PMID: 23664541 Free PMC article.

10

Genetic variation at KIT locus may predispose to melanoma.

Bourillon A, Hu HH, Hetet G, Lacapere JJ, André J, Descamps V, Basset-Seguin N, Ogbah Z, Puig S, Saiag P, Bagot M, Bensussan A, Grandchamp B, Dumaz N, Soufir N. Bourillon A, et al. Among authors: andre j. Pigment Cell Melanoma Res. 2013 Jan;26(1):88-96. doi: 10.1111/pcmr.12032. Epub 2012 Nov 23. Pigment Cell Melanoma Res. 2013. PMID: 23020152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,132 results

Search Page

Filters